ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,244.80
1.57%
다우존스 지수
38,239.66
0.40%
Bitcoin
63,170.31
-0.89%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. T2 Biosystems Inc (TTOO)

  7. T2 Biosystems Inc (TTOO) 뉴스

TTOO T2 Biosystems Inc

2.81
0.07 (2.55%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
T2 Biosystems Inc TTOO 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.07 2.55% 2.81 09:00:00
개장가 저가 고가 종가 전일 종가
2.76 2.7001 2.9353 2.84 2.74
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
24/04/202422:00GLOBET2 Biosystems to Report First Quarter 2024 Financial Results..
12/04/202405:05GLOBET2 Biosystems Shareholders Vote for CRG Debt Conversion into..
28/03/202422:00GLOBET2 Biosystems Announces Extension of Multi-Year Capital..
20/03/202420:30GLOBET2 Biosystems Unveils T2Lyme Launch Plans and Provides..
19/03/202422:00GLOBET2 Biosystems to Host Investor Call on March 20, 2024 to..
18/03/202422:00GLOBET2 Biosystems Announces New Publication Highlighting the..
12/03/202422:00GLOBET2 Biosystems Receives Extension to Comply with Nasdaq..
05/03/202406:34EDGAR2Form DEF 14A - Other definitive proxy statements
28/02/202406:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/02/202406:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/02/202406:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/02/202406:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/02/202406:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/02/202406:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/02/202406:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202407:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202407:00EDGAR2Form 8-K - Current report
16/02/202406:49EDGAR2Form PRE 14A - Other preliminary proxy statements
16/02/202406:47EDGAR2Form 8-K - Current report
16/02/202406:06GLOBET2 Biosystems Announces Preliminary Fourth Quarter and Full..
16/02/202406:04GLOBET2 Biosystems Announces Agreement with CRG for the..
16/02/202406:02GLOBET2 Biosystems Announces Commercial Expansion Through..
14/02/202410:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/02/202423:00GLOBET2 Biosystems Receives FDA 510(k) Clearance for the Expanded..
08/02/202406:05GLOBET2 Biosystems to Report Fourth Quarter and Full Year 2023..
18/01/202423:00GLOBET2 Biosystems Announces Participation in NIH-funded..
06/01/202406:00EDGAR2Form 8-K - Current report
04/01/202406:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/01/202423:00GLOBET2 Biosystems Announces FDA 510(k) Submission to Expand Use..
29/11/202306:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202306:00EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
25/11/202306:30EDGAR2Form 8-K/A - Current report: [Amend]
03/11/202322:00GLOBET2 Biosystems to Participate in the Canaccord Genuity..
01/11/202322:08EDGAR2Form 8-K - Current report
01/11/202322:00GLOBET2 Biosystems Regains Compliance with Nasdaq Listing..
25/10/202322:02EDGAR2Form 8-K - Current report
25/10/202305:05GLOBET2 Biosystems Highlights New Clinical Data Presented at..
23/10/202322:00EDGAR2Form 8-K - Current report
23/10/202322:00GLOBET2 Biosystems Announces Amendment and Extension of CRG Term..
21/10/202305:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/10/202305:31EDGAR2Form 8-K - Current report
13/10/202305:32EDGAR2Form 8-K - Current report
13/10/202305:05GLOBET2 Biosystems Announces Preliminary Third Quarter 2023..
13/10/202305:02GLOBET2 Biosystems Announces FDA 510(k) Submission to Expand the..
13/10/202305:01EDGAR2Form 8-K - Current report
12/10/202322:00GLOBET2 Biosystems Announces Reverse Stock Split Effective Today
12/10/202306:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/10/202306:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/10/202306:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/10/202306:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..

최근 히스토리

NASDAQ
TTOO
T2 Biosystems
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유